Oscar Health, Inc. (OSCR)
| Market Cap | 9.97B +112.7% |
| Revenue (ttm) | 17.47B +54.8% |
| Net Income | 855.47M |
| EPS | 2.66 |
| Shares Out | 310.37M |
| PE Ratio | 12.09 |
| Forward PE | 14.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,709,017 |
| Open | 33.74 |
| Previous Close | 33.47 |
| Day's Range | 32.04 - 34.20 |
| 52-Week Range | 10.69 - 38.50 |
| Beta | 2.49 |
| Analysts | Hold |
| Price Target | 37.00 (+15.23%) |
| Earnings Date | Nov 5, 2026 |
About OSCR
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health prod... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for OSCR stock is "Hold." The 12-month stock price target is $37.0, which is an increase of 15.23% from the latest price.
News
Oscar Health now available in nearly all of Ohio
Oscar, a part of Oscar Health (OSCR), announced it is now available in nearly all of Ohio. Oscar is entering 33 new Ohio counties, including the Akron, Canton, Toledo, and…
Oscar Health launches consumer health products across South Carolina
Oscar, a part of Oscar Health (OSCR), introduced its health products across South Carolina on the ACA marketplace for 2027 Open Enrollment. Oscar is entering the South Carolina counties of…
HealthEx Partners with Oscar Insurance to Bring Members' Medical Records Into the Oscar App
SAN FRANCISCO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- HealthEx today announced a collaboration with Oscar Insurance (NYSE: OSCR) to bring members' health records into the Oscar app from their first day of ...
Oscar Health price target raised to $38 from $36 at UBS
UBS raised the firm’s price target on Oscar Health (OSCR) to $38 from $36 and keeps a Neutral rating on the shares.
Oscar Health price target lowered to $45 from $48 at Piper Sandler
Piper Sandler lowered the firm’s price target on Oscar Health (OSCR) to $45 from $48 and keeps an Overweight rating on the shares following the Q3 beat and raise. The…
Oscar Health Earnings Call Transcript: Q3 2026
9M operating earnings reached $1.3B, and FY 2026 operating earnings guidance rose to $850M-$950M. Membership grew 27% YoY, while 2027 planning assumes a stable ACA market and ~14% weighted average rate increases.
Oscar Health Earnings release: Q3 2026
Oscar Health released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Oscar Health Quarterly report: Q3 2026
Oscar Health has published its Q3 2026 quarterly earnings report on November 5, 2026.
Oscar Health reports Q3 EPS 49c, consensus (17c)
Reports Q3 revenue $5.14B, consensus $4.72B. “Oscar Health (OSCR) is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from…
Oscar Health raises 2026 revenue view to $19.0B-$19.3B from $18.7B-$19.0B
2026 revenue consensus $18.73B. Raises 2026 outlook for earnings from operations to $850M-$950M from $600M-$800M.
Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook
NEW YORK--(BUSINESS WIRE)--Oscar Health announced its financial results for the third quarter ended September 30, 2026, and updates to its full year 2026 outlook.
Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing.
The stocks of big operators in state Medicaid programs, Affordable Care Act markets and hospital groups all jumped.
Oscar Health price target raised to $36 from $26 at UBS
UBS raised the firm’s price target on Oscar Health (OSCR) to $36 from $26 and keeps a Neutral rating on the shares. The firm expects Oscar Health to post a…
Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call
NEW YORK--(BUSINESS WIRE)--Oscar Health will release its third quarter 2026 financial results on Thursday, November 5, 2026.
Oscar Health put volume heavy and directionally bearish
Bearish flow noted in Oscar Health (OSCR) with 5,772 puts trading, or 1.5x expected. Most active are 10/9 weekly 29 puts and 10/2 weekly 34 calls, with total volume in…
Oscar Health initial stock reaction on CMS news overdone, says Raymond James
Raymond James reiterated an Outperform rating and $42 price target on Oscar Health (OSCR) after the Centers for Medicare & Medicaid Services announced ACA Marketplace program-integrity actions, includ...
Oscar Health Announces Thrive Capital's Completion of Oscar Health Common Stock Distribution to its Limited Partners
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar Health” or the “Company”) (NYSE: OSCR) announced that on September 18, 2026 certain funds affiliated with or advised by Thrive Capital Management,...
Oscar Health price target raised to $42 from $34 at Raymond James
Raymond James raised the firm’s price target on Oscar Health (OSCR) to $42 from $34 and keeps an Outperform rating on the shares. Management raised its long-term outlook with a…
Oscar Health price target raised to $30 from $28 at BofA
BofA raised the firm’s price target on Oscar Health (OSCR) to $30 from $28 and keeps an Underperform rating on the shares after the company updated their 2026 guidance to…
Oscar Health price target raised to $33 from $27 at Baird
Baird analyst Michael Ha raised the firm’s price target on Oscar Health (OSCR) to $33 from $27 and keeps a Neutral rating on the shares. The firm updated its model…
Oscar Health price target raised to $34 from $30 at Goldman Sachs
Goldman Sachs analyst Scott Fidel raised the firm’s price target on Oscar Health (OSCR) to $34 from $30 and keeps a Neutral rating on the shares. Oscar Health’s Investor Day…
Oscar Health increased earnings from operations outlook at investor day
Oscar Health (OSCR) yesterday discussed its financial performance and outlook at the company’s investor day, including the following improvements to its full year 2026 guidance: Medical loss ratio bet...
Oscar Health Transcript: Investor Day 2026
Raised 2026 earnings guidance to $600M–$800M and reaffirmed long-term targets of 20%+ revenue CAGR, 5%–7% margins, and $4+ EPS by 2029. Growth will be driven by ACA expansion, Choice adoption, AI-driven efficiencies, and the Lucie Health Marketplace, with significant investments in technology and product innovation.